These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 372836)

  • 1. Antitumor effect of sublethal irradiation caused by its tolerance abrogating capacity.
    Donovan G; Badea E; Popp I
    Neoplasma; 1979; 26(1):89-93. PubMed ID: 372836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of the immune response to tumor antigens. II. The nature of immunosuppressor cells in tumor-bearing hosts.
    Fujimoto S; Greene MI; Sehon AH
    J Immunol; 1976 Mar; 116(3):800-6. PubMed ID: 1254955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A time factor in the success or failure of immune rejection of transplanted tumors.
    Vaage J
    Cancer Res; 1977 Apr; 37(4):1064-7. PubMed ID: 844038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regualtion of the immune response to tumor antigens. I. Immunosuppressor cells in tumor-bearing hosts.
    Fujimoto S; Greene MI; Sehon AH
    J Immunol; 1976 Mar; 116(3):791-9. PubMed ID: 1082894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-reactive cellular and humoral immunity to carcinogen-induced chicken fibrosarcomas. I. Protective cross-immunity between transplantable tumor lines.
    Edelman AS; Xue B; Sanchez P; Thorbecke GJ
    J Immunol; 1985 Sep; 135(3):2206-12. PubMed ID: 3926898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Common transplantation antigens on methylcholanthrene-induced murine sarcomas detected by three assays of tumor rejection.
    Leffell MS; Coggin JH
    Cancer Res; 1977 Nov; 37(11):4112-9. PubMed ID: 908044
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibition of transplanted sarcomas mediated by BCG in rats with a defined immunological deficit.
    Moore M; Lawrence N; Nisbet NW
    Biomedicine; 1976 Jan; 24(1):26-31. PubMed ID: 773443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of thymectomy on tumor development and on T and B lymphocytes in tumor-bearing rats.
    Klobusická M; Koníková E; Novotná L
    Neoplasma; 1979; 26(4):413-21. PubMed ID: 392324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrathymic injection of donor-specific X-irradiation-sensitive spleen cells abrogates accelerated rejection of cardiac allografts in sensitized rats.
    Binder J; Sayegh MH; Watschinger B; Hancock WW; Kupiec-Weglinski JW
    Transplantation; 1994 Jul; 58(1):80-6. PubMed ID: 8036712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor effect of whole-body X-irradiation: possible role of an X-ray-sensitive T suppressor cell population.
    Hellström I; Hellström KE
    Transplant Proc; 1979 Mar; 11(1):1073-6. PubMed ID: 313092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of host antigen receptor-bearing and antigen receptor-negative cells in immune response to rat adenocarcinoma 13762.
    Frey AB
    J Immunol; 1996 May; 156(10):3841-9. PubMed ID: 8621922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous protection against allograft rejection and graft-versus-host disease after total lymphoid irradiation: role of natural killer T cells.
    Liu YP; Li Z; Nador RG; Strober S
    Transplantation; 2008 Feb; 85(4):607-14. PubMed ID: 18347541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The specificity of concomitant tumor immunity at large tumor volumes.
    Deckers PJ; Pardridge DH; Wang BS; Mannick JA
    Cancer Res; 1976 Oct; 36(10):3690-4. PubMed ID: 953994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation.
    Strober S
    Blood Cells Mol Dis; 2008; 40(1):48-54. PubMed ID: 17827036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Self-tolerance restoration of irradiated graft-versus-host mice after thymus grafting.
    Baron C; Bierre V; Weil B; Lang P
    Transplant Proc; 1995 Aug; 27(4):2486-7. PubMed ID: 7652898
    [No Abstract]   [Full Text] [Related]  

  • 16. Evidence of cell-mediated antitumor immunity in rats bearing syngeneic tumors by the leukocyte adherence inhibition test.
    Kalafut F; Hung PM; Novotná L; Grófová M
    Neoplasma; 1978; 25(5):569-75. PubMed ID: 310970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrophage tumoricidal activity as a possible antitumor mechanism associated with the local injection of allogeneic spleen cells into rats.
    Kawase I; Komuta K; Namba M; Yokota S; Ogura T; Kishimoto S
    Cancer Res; 1986 Mar; 46(3):1047-54. PubMed ID: 3510719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potent graft antitumor effect in natural killer-resistant disseminated tumors by transplantation of interleukin 2-activated syngeneic bone marrow in mice.
    Agah R; Malloy B; Kerner M; Girgis E; Bean P; Twomey P; Mazumder A
    Cancer Res; 1989 Nov; 49(21):5959-63. PubMed ID: 2790810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular immunity to solubilized tumor antigens of a methylcholanthrene-induced sarcoma with a migration inhibition assay.
    Padarathsingh ML; Dean JH; McCoy JL; Lewis DD; Northing JW; Natori T; Law LW
    J Immunol; 1978 Jun; 120(6):1981-5. PubMed ID: 659888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hematopoietic reconstitution after lethal irradiation and bone marrow transplantation: effects of different hematopoietic cytokines on the recovery of thymus, spleen and blood cells.
    Frasca D; Guidi F; Arbitrio M; Pioli C; Poccia F; Cicconi R; Doria G
    Bone Marrow Transplant; 2000 Feb; 25(4):427-33. PubMed ID: 10723587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.